Skip to main content
. 2022 Aug 24;14(17):4103. doi: 10.3390/cancers14174103

Table 2.

Rates of KRAS mutations in NSCLC and subtypes.

Cancer Mutation Rates
KRAS KRAS Exon 2 Mutations Rate KRAS Exon 3 Mutations Rate KRAS Exon 4 Rate Considering the Total of KRAS Mutations
NSCLC 25–30% 34% 1.89% 0.24%
Lung AC 30–35% 27% 7% <1%
SCC 3–4% 7% <3% <0.5%

AC: AdenoCarcinoma; NSCLC: Non-Small Cell Lung Cancer; SCC: Squamous-Cell Carcinoma (AACR Project GENIE Consortium, 2017 [7]).